ArticleCurrent cancer drug targets2025

HAND2-AS1 Promotes Ferroptosis to Reverse Lenvatinib Resistance in Hepatocellular Carcinoma by TLR4/NOX2/DUOX2 Axis.

Zheng Song et al.PubMed ↗Publisher ↗

No numbers read from the abstract.